+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American Pen Needle Market 2020-2026

  • PDF Icon


  • October 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5240834
North American Pen Needle Market Size, Share & Trends Analysis Report By Type (Standard and Safety), By Therapy (Insulin, GLP-1, Growth Hormones), By Mode of Purchase (Retail and Non-Retail), and Forecast 2020-2026.

The North American pen needle market is anticipated to grow at a CAGR of 7.5% during the forecast period. The major factor influencing the growth of the pen needle market includes high awareness amongst the people related to the availability of such products in the market. In addition, increasing government funding and investment in R&D by government bodies and pharmaceutical and biotechnology companies are also positively impacting market growth. Further, a rise in the number of diabetic patients, rising awareness towards diabetes care, frequent advancements in pen needles among others are the crucial factors contributing to the high share of the regional market.

The North American pen needle market is segmented based on type, therapy, and mode of purchase. Based on the type, the market is sub-segmented into a standard pen needle and safety pen needle. The standard pen needles segment is estimated to contribute a significant share in the market. Based on the therapy, the market is sub-segmented into, insulin, GLP-1, growth hormones. Pen needles for insulin are estimated to contribute a prominent share in the market and are projected to do so during the forecast period. Based on the mode of purchase, the market is bifurcated into retail and non-retail. The retail segment is estimated to contribute significantly to market growth.

Some of the players of the North American Pen Needle market include Becton, Dickinson and Co., Novo Nordisk A/S, Domrex Pharma, Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies including mergers, and acquisitions, collaborations, and funding, to stay competitive in the market.

Research Methodology

The market study of the North American pen needle market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pen needles manufacturers, insulin pen manufacturers, component manufacturers, government organizations, regulatory bodies, hospitals & pharmacies, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and growth opportunities in the market. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. North America Pen Needle Market Research and Analysis by Type
2. North America Pen Needle Market Research and Analysis by Therapy
3. North America Pen Needle Market Research and Analysis by Mode of Purchase

The Report Covers:
  • Comprehensive research methodology of the North American pen needle market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American pen needle market.
  • Insights about market determinants which are stimulating the North American pen needle market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. North AmericaPen NeedleMarket by Type
4.1.1. Standard Pen Needles
4.1.2. Safety Pen Needles
4.2. North America Pen Needle Market by Therapy
4.2.1. Insulin
4.2.2. GLP-1
4.2.3. GrowthHormones
4.3. North AmericaPen Needle Market by Mode of Purchase
4.3.1. Retail
4.3.2. Non-Retail
5. Regional Analysis
5.1. United States
5.2. Canada
6. Company Profiles
6.1. AgaMatrix, Inc.
6.2. Allison Medical, Inc.
6.3. Becton, Dickinson and Co.
6.4. Domrex Pharma, Inc.
6.5. MHC Medical
6.6. Montméd inc.
6.7. Novo Nordisk A/S
6.8. Trividia Health, Inc.
6.9. Ultimed, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AgaMatrix, Inc.
  • Allison Medical, Inc.
  • Becton, Dickinson and Co.
  • Domrex Pharma, Inc.
  • MHC Medical
  • Montméd inc.
  • Novo Nordisk A/S
  • Trividia Health, Inc.
  • Ultimed, Inc.